Conversely, our group reported a reduced pIgR expression in the bronchial epithelium from patients with asthma, with in vitro experiments indicating that IL-4R activation (and thus a type 2 immune environment) may account for this epithelial defect in asthma (68). The gene discussed is IL4R; the disease is asthma.